Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Urologic Neoplasms × Cyclophosphamide × Clear all

Sponsor

Conditions

Breast Neoplasms 138 Lymphoma 137 Precursor Cell Lymphoblastic Leukemia-Lymphoma 113 Lymphoma, Non-Hodgkin 107 Leukemia 106 Leukemia, Lymphocytic, Chronic, B-Cell 102 Multiple Myeloma 100 Lymphoma, Large B-Cell, Diffuse 86 Leukemia, Myeloid, Acute 83 Hodgkin Disease 72 Myelodysplastic Syndromes 70 Lymphoma, Follicular 67 Lymphoma, Mantle-Cell 66 Burkitt Lymphoma 59 Lymphoma, B-Cell, Marginal Zone 47 Melanoma 44 Neoplasms 40 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 39 Recurrence 32 Lymphoma, Large-Cell, Immunoblastic 31 Hematologic Neoplasms 31 Neoplasms, Plasma Cell 28 Leukemia, Myelomonocytic, Chronic 27 Myeloproliferative Disorders 26 Primary Myelofibrosis 24 Lymphoma, Large-Cell, Anaplastic 24 Lymphoma, B-Cell 24 Congenital Abnormalities 24 Leukemia, Myeloid, Chronic-Phase 23 Leukemia, Myeloid, Accelerated Phase 23

Interventions

Trastuzumab 2 valrubicin 1 niraparib 1 enfortumab vedotin 1 avelumab 1 Surveys and Questionnaires 1 Sunitinib 1 Sugammadex 1 Standard of Care 1 Paclitaxel 1 Neostigmine 1 Neoadjuvant Therapy 1 Gemcitabine 1 Docetaxel 1 Cisplatin 1 Cetuximab 1 Afatinib 1 Administration, Intravesical 1 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡